Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.14 | $0.14 | $0.14 |
| Q2 2026 | 1 | $0.16 | $0.16 | $0.16 |
| Q3 2026 | 1 | $0.33 | $0.33 | $0.33 |
| Q4 2026 | 1 | $0.37 | $0.37 | $0.37 |
| Q1 2027 | 1 | $0.29 | $0.29 | $0.29 |
| Q2 2027 | 1 | $0.30 | $0.30 | $0.30 |
| Q3 2027 | 1 | $0.32 | $0.32 | $0.32 |
| Q4 2027 | 1 | $0.34 | $0.34 | $0.34 |
Avanos Medical Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $0.22 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.06. The company had revenue of 182.20 M for the quarter and had revenue of 701.20 M for the year. Avanos Medical Inc has generated $-1 earnings per share over the last year ($-1.46 diluted earnings per share) and currently has a price-to-earnings ratio of -16.53. Avanos Medical Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | $0.16 | $0.11 | -0.05 | $170.00 M | $182.20 M |
| 02/24/2026 | Q4 2025 | $0.24 | $0.08 | -0.16 | $174.70 M | $180.90 M |
| 11/05/2025 | Q3 2025 | $0.12 | -$0.03 | -0.15 | $164.50 M | $177.80 M |
| 08/05/2025 | Q2 2025 | $0.18 | -$1.66 | -1.84 | $165.50 M | $175.00 M |
| 05/06/2025 | Q1 2025 | $0.19 | $0.14 | -0.05 | $161.75 M | $167.50 M |
| 02/26/2025 | Q4 2024 | $0.40 | -$8.64 | -9.04 | $177.25 M | $179.60 M |
| 10/30/2024 | Q3 2024 | $0.36 | $0.09 | -0.27 | $175.33 M | $170.40 M |
| 07/31/2024 | Q2 2024 | $0.29 | $0.04 | -0.25 | $170.67 M | $171.70 M |
| 05/02/2024 | Q1 2024 | $0.21 | -$0.02 | -0.23 | $162.90 M | $166.10 M |
| 02/20/2024 | Q4 2023 | N/A | $0.23 | N/A | N/A | $173.30 M |
| 11/01/2023 | Q3 2023 | $0.29 | -$0.08 | -0.37 | N/A | $171.30 M |
| 08/09/2023 | Q2 2023 | $0.34 | -$1.46 | -1.8 | N/A | $169.40 M |
| 05/03/2023 | Q1 2023 | $0.28 | -$0.01 | -0.29 | N/A | $159.30 M |
| 02/21/2023 | Q4 2022 | $0.48 | $0.36 | -0.12 | N/A | $181.60 M |
| 11/02/2022 | Q3 2022 | $0.35 | $0.34 | -0.01 | N/A | $172.30 M |
| 08/09/2022 | Q2 2022 | $0.39 | $0.24 | -0.15 | N/A | $170.90 M |
| 05/04/2022 | Q1 2022 | $0.24 | $0.12 | -0.12 | N/A | $197.40 M |
| 02/23/2022 | Q4 2021 | $0.40 | $0.21 | -0.19 | N/A | $193.40 M |
| 11/02/2021 | Q3 2021 | $0.27 | -$0.73 | -1 | N/A | $184.10 M |
| 08/03/2021 | Q2 2021 | $0.23 | $0.79 | 0.56 | N/A | $186.40 M |
In the previous quarter, Avanos Medical Inc (:AVNS) reported $0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $0.16 by $0.06.
The conference call for Avanos Medical Inc's latest earnings report can be listened to online.
The conference call transcript for Avanos Medical Inc's latest earnings report can be read online.
Avanos Medical Inc (:AVNS) has a recorded annual revenue of $701.20 M.
Avanos Medical Inc (:AVNS) has a recorded net income of $-67,900,000.Avanos Medical Inc has generated $-1.46 earnings per share over the last four quarters.
Avanos Medical Inc (:AVNS) has a price-to-earnings ratio of -16.53 and price/earnings-to-growth ratio is -0.38.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED